<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Bi-69a11, a Novel Akt Inhibitor, Exerts Anti Tumor Effects in Colon Carcinoma by Modulating Akt and its Downstrem Signaling...</title>
<link href="http://127.0.0.1/xmlui/handle/123456789/5654" rel="alternate"/>
<subtitle/>
<id>http://127.0.0.1/xmlui/handle/123456789/5654</id>
<updated>2026-04-18T00:21:56Z</updated>
<dc:date>2026-04-18T00:21:56Z</dc:date>
<entry>
<title>Bi-69a11, a Novel Akt Inhibitor, Exerts Anti Tumor Effects in Colon Carcinoma by Modulating Akt and its Downstrem Signaling to Potentiate Current Therapeutic Efficacy</title>
<link href="http://127.0.0.1/xmlui/handle/123456789/5655" rel="alternate"/>
<author>
<name>Pal, Ipsita</name>
</author>
<id>http://127.0.0.1/xmlui/handle/123456789/5655</id>
<updated>2015-12-01T12:08:12Z</updated>
<published>2015-07-01T00:00:00Z</published>
<summary type="text">Bi-69a11, a Novel Akt Inhibitor, Exerts Anti Tumor Effects in Colon Carcinoma by Modulating Akt and its Downstrem Signaling to Potentiate Current Therapeutic Efficacy
Pal, Ipsita
</summary>
<dc:date>2015-07-01T00:00:00Z</dc:date>
</entry>
</feed>
